Mayo Clinic Study Redefines Surgical Risk for Adults with Congenital Heart Disease

A new study led by Dr. Elaine Griffeth at Mayo Clinic is working to improve surgical risk prediction for adults with congenital heart disease (CHD). Many of these patients face multiple high-risk reoperations, yet current risk assessment tools fail to account for their unique medical needs. The research aims to create a more accurate model to help doctors evaluate risks before complex surgeries.

The study focused on adults with CHD undergoing redo cardiac procedures, a group often excluded from standard risk models. Researchers analysed data from the STS Adult Cardiac Surgery Database (ACSD) collected between July 2017 and December 2023. By excluding patients having first-time surgeries or isolated coronary bypasses, the team honed in on those most likely to experience severe postoperative complications.

About 16.7% of these high-risk patients face increased mortality or major complications after reoperations. The study identified 15 key clinical factors that strongly influence outcomes, addressing gaps where existing models fall short. Since traditional risk tools don't account for the altered anatomy and physiology of CHD patients, the team used advanced analytical methods to adjust for incomplete data in the ACSD.

The refined model showed strong predictive power, offering a more reliable way to assess surgical risks. By standardising risk evaluation, the findings could help ensure fairer and more informed clinical decisions for this patient group.

The research provides a clearer way to predict surgical risks for adults with CHD needing reoperations. With 15 critical variables now identified, doctors may soon have a dedicated tool to improve preoperative planning. This could lead to better outcomes for a patient group that often requires lifelong cardiac care.